Cleared Traditional

K063343 - BIOPTIGEN SPECTRAL DOMAIN OPHTHALMIC IMAGING SYSTEM

K063343 is an FDA 510(k) clearance for BIOPTIGEN SPECTRAL DOMAIN OPHTHALMIC IM..., manufactured by Bioptigen, Inc.. The device is a Class 2 Ophthalmic device with product code HLI cleared through the Traditional 510(k) pathway after a 37-day FDA review.

K063343 · Bioptigen, Inc. · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2006
Decision
37d
Days
Class 2
Risk

K063343 is an FDA 510(k) clearance for the BIOPTIGEN SPECTRAL DOMAIN OPHTHALMIC IMAGING SYSTEM. Classified as Ophthalmoscope, Ac-powered (product code HLI), Class II - Special Controls.

Submitted by Bioptigen, Inc. (Washington, US). The FDA issued a Cleared decision on December 13, 2006 after a review of 37 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.1570 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Bioptigen, Inc. devices

FDA 510(k) Submission Details - K063343

510(k) Number K063343 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 06, 2006
Decision Date December 13, 2006
Days to Decision 37 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Regulatory Context
Review time vs. panel average
73d faster than avg
Panel avg: 110d · This submission: 37d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

HLI Device Classification - Class 2, Special Controls

Product Code HLI Ophthalmoscope, Ac-powered
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.1570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HLI Ophthalmoscope, Ac-powered

All 71
Devices cleared under the same product code (HLI) and FDA review panel - the closest regulatory comparables to K063343.
RTVUE MODEL RTVUE 100
K101505 · Optovue, Inc. · Sep 2010
R T VUE WITH SOFTWARE 5.0 MODEL: R I VUE 100
K100861 · Optovue, Inc. · Jun 2010
CIRRUS HD-OCT, MODEL 4000
K063378 · Carl Zeiss Meditec, Inc. · Jan 2007
VANTAGE INDIRECT OPHTHALMOSCOPE
K060822 · Keeler Instruments, Inc. · May 2006
VISANTE OCT
K051789 · Carl Zeiss Meditec, Inc. · Sep 2005
OCT-OPTHALMOSCOPE
K042885 · Ophthalmic Technologies, Inc. · Jan 2005